Specialised Therapeutics  logo — We collaborate with global biotech partners to commercialise...

Specialised Therapeutics

We collaborate with global biotech partners to commercialise specialist therapies in Australia, New Zealand & SE Asia.

Founded 2007 Singapore Singapore 36 employees

General Information

Company Name Specialised Therapeutics
Founded Year 2007
Location Singapore Singapore +3
Employees 36
Social

Get notified when Specialised Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Specialised Therapeutics

Specialised Therapeutics, founded in 2007, is a prominent international pharmaceutical company that specializes in providing advanced medicines to patients in Australia, New Zealand, and South East Asia. Established by Carlo Montagner and Bozena Zembrzuski, the company has significantly expanded its product portfolio since its inception, extending to areas such as oncology, haematology, neurology, supportive care, genomic assays, and ophthalmology. With its headquarters in Singapore and representative offices in Australia and New Zealand, Specialised Therapeutics has established partnerships with renowned international biotech and pharmaceutical companies such as Incyte Biosciences International, Celgene (acquired by BMS), and Puma Biotechnology. The company excels in guiding products from pre-registration to full commercialization in key regions, leveraging its expertise in navigating complex regulatory and reimbursement pathways. Noteworthy partners also include Helsinn Healthcare, photonamic GmbH, and Ariad Pharmaceuticals (now Takeda Pharmaceuticals), among others. Specialised Therapeutics stands out for its exceptional track record in successfully commercializing specialty products and its commitment to collaborating with global biotech partners to bring specialized therapies to the region.

Taxonomy: specialist therapies, oncology, haematology, neurology, pharmaceutical commercialisation, biotech partnerships, regulatory pathways, reimbursement strategies, international market expansion, genomic assays, ophthalmology, healthcare logistics, medical affairs, sales and marketing

No funding data available for Specialised Therapeutics yet.

Get notified when Specialised Therapeutics raises funding

Specialised Therapeutics Alternatives & Competitors

Specialised Therapeutics vs

Agspec is a leading distributor of fertilisers, crop protection and specialty nutrient products in A...

7 employees
Agriculture, Retail
Specialised Therapeutics vs

Disphar International BV has become Esperante Development. https://www.linkedin.com/company/esperant...

13 employees
Specialised Therapeutics vs

Helping patients become people again

Post Ipo Debt
71 employees
Biotechnology, Health and Wellness

FAQ About Specialised Therapeutics

We collaborate with global biotech partners to commercialise specialist therapies in Australia, New Zealand & SE Asia.
Specialised Therapeutics was founded in 2007.
Specialised Therapeutics is headquartered in Singapore.
Specialised Therapeutics has approximately 36 employees.
Top alternatives and competitors to Specialised Therapeutics include Agspec Australia , Disphar International BV, Shield Therapeutics plc, Ovation Pharmaceuticals, SPLOSH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Specialised Therapeutics and Agspec Australia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Specialised Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy